BACKGROUND: Accurate methods to preoperatively characterize adnexal tumors are pivotal for optimal patient management. A recent metaanalysis concluded that the International Ovarian Tumor Analysis algorithms such as the Simple Rules are the best approaches to preoperatively classify adnexal masses as benign or malignant. OBJECTIVE: We sought to develop and validate a model to predict the risk of malignancy in adnexal masses using the ultrasound features in the Simple Rules. STUDY DESIGN: This was an international cross-sectional cohort study involving 22 oncology centers, referral centers for ultrasonography, and general hospitals. We included consecutive patients with an adnexal tumor who underwent a standardized transvaginal ultrasound examination and were selected for surgery. Data on 5020 patients were recorded in 3 phases from 2002 through 2012. The 5 Simple Rules features indicative of a benign tumor (B-features) and the 5 features indicative of malignancy (M-features) are based on the presence of ascites, tumor morphology, and degree of vascularity at ultrasonography. Gold standard was the histopathologic diagnosis of the adnexal mass (pathologist blinded to ultrasound findings). Logistic regression analysis was used to estimate the risk of malignancy based on the 10 ultrasound features and type of center. The diagnostic performance was evaluated by area under the receiver operating characteristic curve, sensitivity, specificity, positive likelihood ratio (LRþ), negative likelihood ratio (LRe), positive predictive value (PPV), negative predictive value (NPV), and calibration curves.
Introduction
Ovarian cancer is a common and lethal disease for which early detection and treatment in high-volume centers and by specialized clinicians is known to improve survival. [1] [2] [3] [4] Hence, accurate methods to preoperatively characterize the nature of an ovarian tumor are pivotal. In 2008 the International Ovarian Tumor Analysis (IOTA) group described the Simple Rules. Masses in which the Simple Rules yield an inconclusive result can be classified using subjective assessment by an experienced ultrasound operator or, given the high prevalence of malignancy in this group, they can all be classified as malignant to increase the sensitivity for ovarian cancer. 6 On prospective validation both by the IOTA group (2 studies including 1938 and 2403 patients, respectively) 7, 8 and by other research teams (9 studies including a total of 2101 tumors), [9] [10] [11] [12] [13] [14] [15] [16] [17] the Simple Rules were applicable in 77-94% of tumors (range between studies). The malignancy rate ranged from 1-9% in cases classified as benign, from 69-94% in cases classified as malignant, and from 13-53% in inconclusive cases. In a metaanalysis comparing the ability of 19 methods to discriminate between benign and malignant adnexal masses before surgery, the Simple Rules had a sensitivity of 93% and a specificity of 81% when classifying inconclusive tumors as malignant. 18 In the metaanalysis the Simple Rules and the IOTA logistic regression model 2 19 were superior to all other methods. This suggests that evidence-based approaches to the preoperative characterization of adnexal masses should incorporate the use of Simple Rules or the logistic regression model 2. Logistic regression model 2 is a mathematical risk prediction model based on age and 5 ultrasound variables (presence of blood flow in a papillary structure, irregular cyst walls, ascites, acoustic shadows, and maximum diameter of the largest solid component).
The Simple Rules have been well received by clinicians, and the Royal College of Obstetricians and Gynecologists in the United Kingdom has included the Simple Rules in their Green Top guideline on the assessment and management of ovarian masses in premenopausal women. 20 Despite a combination of simplicity and excellent performance, important limitations of the Simple Rules are the inconclusive results in a proportion of cases and the absence of an estimated risk of malignancy. The ability to provide accurate risk estimates is highly relevant for risk stratification and individualized patient management. The objective of this study was to develop and validate a model to calculate the risk of malignancy in adnexal masses based on the 10 ultrasound features in the Simple Rules.
Materials and Methods

Study design and setting
This international multicenter crosssectional cohort study involves patients from 22 centers (oncology centers and other hospitals) ( Table 1) with at least 1 adnexal (ovarian, paraovarian, or tubal) tumor selected for surgery by the managing clinician. Exclusion criteria were: (1) pregnancy at the time of examination, (2) refusal of transvaginal ultrasonography, (3) declining participation, and (4) surgical intervention >120 days after the ultrasound examination. Data collection was carried out within the framework of the IOTA collaboration. The primary aim of the IOTA studies is to develop and validate methods for making a correct diagnosis in adnexal tumors prior to surgery. This aim is pursued by prospectively examining a large number of patients with ultrasound using a standardized examination technique and standardized terms and definitions to describe ultrasound findings. 
Data collection
Oral and/or written informed consent was obtained in accordance with the requirements of the local ethics committee. A standardized history was taken from each patient to collect clinical information. All patients underwent a standardized transvaginal ultrasound examination by a principal investigator, who was a gynecologist or radiologist with extensive experience in gynecological ultrasound and with a special interest in adnexal masses. Transabdominal sonography was added in women with large masses that could not be visualized completely by the transvaginal approach. For women with multiple masses, the dominant mass was selected for statistical analysis. 8, 19, [21] [22] [23] [24] To apply the Simple Rules, information on the following variables is required: the diameters of the lesion (millimeters), the diameters of the largest solid component (millimeters), type of tumor (unilocular, unilocularsolid, multilocular, multilocular-solid, solid), presence of wall irregularity, ascites, acoustic shadows, number of papillary structures, and the color score, the latter reflecting vascularization on Doppler ultrasound (1, no flow; 2, minimal flow; 3, moderate flow; 4, very strong flow). Detailed information can be found in previous reports. 8, 19, [21] [22] [23] [24] The 5 B-features and the 5 M-features were not directly recorded, but were derived from the variables described above.
Reference standard
The reference standard denotes whether the tumor is benign or malignant based on the histopathologic diagnosis of the tumor following surgical removal. Surgery was performed through laparoscopy or laparotomy, as considered appropriate by the surgeon. Excised tumor tissues were histologically examined at the local center. Histological classification was performed without knowledge of the ultrasound results. Borderline tumors were classified as malignant.
Statistical analysis
Using the IOTA data from phases 1b and 2, we estimated the risk of malignancy by quantifying the predictive value of each of the 10 features of the Simple Rules and of the type of center in which the patients underwent an ultrasound examination (oncology center vs other hospital; the definition of oncology center being tertiary referral center with a specific gynecological oncology unit). The predictive values for malignancy were determined by the regression coefficients estimated by multivariable logistic regression. Interaction terms were not considered. The analysis included a random intercept to account for variability between centers. 25 The risk estimates were externally validated on IOTA phase 3 data. The area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and predictive values were calculated through a metaanalysis of center-specific results, 26 similar to a previous validation study using phase 3 data. 8 Positive likelihood ratio (LRþ) and negative likelihood ratio (LRe) were derived from these results. The risk cutoffs considered to classify a mass as malignant were 1%, 3%, 5%, 10%, 15%, 20%, 25%, and 30%. Calibration plots were constructed to assess the relationship between calculated risks and observed proportions. 25, 27 After external validation, the risk calculation was updated using the same procedure but now using all available data (phases 1b, 2, and 3) to fully exploit all available information.
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Results
During IOTA phases 1b, 2, and 3, data on 5020 patients were recorded at 22 centers (2 centers from IOTA phase 1 did not take part in later phases). Data on 172 patients were excluded because the patients fulfilled an exclusion criterion (n ¼ 124; 43 women were pregnant and 81 women were operated on >120 days after the ultrasound examination), data errors or uncertain/missing final histology (n ¼ 47), or protocol violation (n ¼ 1). This leaves data on 4848 patients (Tables 1, 2 , and 3). The development set (phases 1b and 2) contains data on 2445 patients recruited at 11 oncology centers (n ¼ 1548) and 8 other centers (n ¼ 897). The temporal validation set (phase 3) contains data on 2403 patients recruited at 11 oncology centers (n ¼ 1715) and 7 other centers (n ¼ 688).
The malignancy rate was 34% (1665/ 4848) overall, 43% (1402/3263) in oncology centers, and 17% (263/1585) in other centers. The observed malignancy rate varied between 22-66% at oncology centers and between 0-30% at other centers. The median age was 42 years (interquartile range 32-54) for patients with a benign tumor and 57 years (interquartile range 47-66) for patients with a malignant tumor. All 80 observed combinations of the ultrasound features in the Simple Rules are listed in Table 4 . For the same combination of features, the observed malignancy rate was usually higher in oncology centers than in other centers. ajog.org
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Results for the development set (n [ 2445)
The coefficients of the regression analysis for the development data are presented in Table 5 . B-features were allocated negative coefficients, and hence decrease the estimated risk of malignancy. M-features were given positive coefficients. Ultrasound examination in an oncology center was assigned a positive coefficient. 
Results for the validation set (n [ 2403)
When externally validated, the AUC was 0.917 (95% CI, 0.902e0.930) (Figure 1 , A). The AUC was very similar in oncology centers (0.917; 95% CI, 0.901e0.931) and in other centers (0.916; 95% CI, 0.873e0.945). In all but 3 centers, the AUC was at least 0.90. Two centers had an AUC of 0.89 and 1 small center had an AUC <0.80 (Figure 2 ). The estimated risks were well calibrated in all validation patients (Figure 1 , B) and when assessed for patients from oncology centers and other hospitals separately ( Figure 3 ). In all, 22.8% of the patients in the validation set had a calculated risk of malignancy <1%, while 48.5% had a calculated risk 30%. For the 1% calculated risk cutoff, sensitivity was 99.7%, specificity 33.7%, LRþ 1.5, LRe 0.010, positive predictive value (PPV) 44.8%, and negative predictive value (NPV) 98.9%. For the 30% calculated risk cutoff, sensitivity was 89.0%, specificity 84.7%, LRþ 5.8, LRe 0.13, PPV 75.4%, and NPV 93.9% (Table 6) . Sensitivity, specificity, PPV, NPV, LRþ, and LRe for the same risk cutoff differed between oncology centers and other centers ( Table 7) .
Results for the total data set
The regression coefficients for the updated analysis on all data (n ¼ 4848) are shown in Table 8 . Feature B1 (unilocular cyst) was most predictive of a benign tumor (coefficient e3.4), while feature B3 (acoustic shadows) was least predictive (coefficient e1.7). Feature M2 (ascites) was most predictive of malignancy (coefficient 2.7) and feature M4 (irregular multilocular-solid tumor with largest diameter 100 mm) was least predictive (coefficient 1.0). Type of center had a coefficient of 0.9.
For example, consider a patient examined at an oncology center and in whom features B3, M2, and M5 are present. This patient has a regression score of e0.97 Table 9 summarizes the range of estimated risks for individual patients depending on the number of B-features and M-features present in the tumor, based on the updated analysis (n ¼ 4848). In general, the estimated risk of malignancy was at least 42.0% if more M-features than B-features were present (N ¼ 1295, 27% of all tumors) and was at most 0.29% when 2 B-features and no M-features were present (N ¼ 175, 3.6% of all tumors). The estimated risk when no feature was present was 48.7% for patients from oncology centers and 27.5% for patients from other centers (Table 10 ).
Comment
Principal findings of the study
In this study we have developed a method to estimate the individual risk of malignancy in an adnexal mass using the ultrasound features in the IOTA Simple Rules. On prospective validation the risk estimates showed good ability to discriminate between benign and malignant tumors (AUC 0.917) and good agreement between the calculated risks of malignancy and the true prevalence of malignancy.
Implications of the work
The Simple Rules are intuitively attractive because of their ease of use. [9] [10] [11] [12] [13] [14] [15] [16] [17] 20 However, when used as originally suggested they allow only a categorization of tumors into 3 groups: benign, malignant, or inconclusive. In this study we show that the Simple Rules can also be used to estimate the risk of malignancy in every adnexal mass and so can be used for individualized patient management. The type of center also needed to be included in our risk estimation, because the risk of a malignant tumor is higher in oncology centers than in others. The B-feature B1 (unilocular cyst) was most predictive of a benign tumor, while the B-feature B3 (acoustic shadows) was least predictive. The M-feature M2 (ascites) was most predictive of malignancy while the Table 9 , this risk of malignancy can be directly read off for 97% of all patients without the need for a computer. The other 3% of patients have tumors with both M-features and B-features, for these patients the precise individual risk estimate needs to be calculated using a computer or mobile app. However, they all belong to the elevated risk and very high-risk groups. Table 10 shows an even simpler classification of patients into different risk groups. Our results may lay the basis for a clinically useful imaging and management system such as the Gynecologic Imaging Reporting and Data System, 28 
FIGURE 1
Validation data performance for the calculated risk of malignancy 
Metaanalysis of center-specific AUCs on the validation data
Forest plot with center-specific validation areas under receiver operating characteristic curve (AUC) (total n ¼ 2403).
BE, Belgium; CI, confidence interval; CZ, Czech Republic; ES, Spain; IT, Italy; NC, not computed; PL, Poland; SE, Sweden.
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Reports of Major Impact GYNECOLOGY ajog.org as shown in Tables 9 and 10 . While the Gynecologic Imaging Reporting and Data System is based on subjective assessment of ultrasound images, this new system would be based on more objective ultrasound criteria and type of center. The Simple Rules risk classification is an alternative to other algorithms such as the Risk of Malignancy Index (RMI), 29 the Risk of Ovarian Malignancy Algorithm (ROMA), 30 OVA-1, 31,32 and the IOTA logistic regression models (logistics regression model 1, logistic regression model 2, 19 Assessment of Different Neoplasias in the Adnexa 24 ). Three studies have compared the IOTA methods with RMI and ROMA on the same study population. 8, 12, 33, 34 logistic regression model 2 and the Simple Rules (classifying inconclusive cases as malignant) reached higher diagnostic accuracies than RMI 8, 12, 33 and logistic regression model 2 outperformed ROMA. 34 These findings were confirmed in a systematic review and metaanalysis comparing the diagnostic performance of 19 prediction models. 18 The multivariate index assay OVA-1 has been validated by 2 large multicenter studies in the United States. 31, 32 OVA-1 has never been compared with IOTA algorithms on the same set of patients, but it seems to have lower specificity at similar sensitivity, resulting in much higher rates of false-positive results. 35, 36 When prospectively validated on IOTA phase 3 data (ie, on the validation set in the present study), the Simple Rules risk estimates, logistic regression model 2, and subjective assessment (using 6 levels of diagnostic confidence) had similar diagnostic performance in terms of discrimination between benign and malignant tumors: the AUC for logistic regression model 2 was 0.918 (95% CI, 0.905e0.930), 8 for subjective assessment 0.914 (95% CI, 0.886e0.936), 8 and for the Simple Rules risk estimate 0.917 (95% CI, 0.902e0.930). The discriminative ability of the ADNEX model was slightly better: AUC 0.943 (95% CI, 0.934e0.952). 24 The ADNEX model has Because cancer antigen-125 is not used as a variable in the Simple Rules, it is not included in the Simple Rules risk classification. However, adding information on serum cancer antigen-125 levels to ultrasound information does not seem to improve mathematical models to discriminate between benign and malignant adnexal masses. 38 Instead of using an algorithm, experienced examiners might still prefer to give an instant diagnosis using the IOTA Easy Descriptors. This is feasible in 42-46% of patients. 8, 39, 40 The Easy Descriptors apply to endometriomas, Reports of Major Impact GYNECOLOGY ajog.org ajog.org GYNECOLOGY Reports of Major Impact dermoid cysts, simple cysts, and obvious malignancies. 39 In future studies, the Simple Rules risk estimates need to be prospectively and externally validated, and their use in a classification system for clinical management has to be investigated.
Strengths and weaknesses
The strength of this study is the use of a large multinational database in which patients were prospectively collected using well-defined terms, definitions, and measurements. After development and temporal validation, the risk calculation was updated using all 4848 patients. The large sample size is likely to yield generalizable results.
The study also has limitations. First, our risk calculation model was developed and validated exclusively on patients who underwent surgery. This is because we found it necessary to use the histological diagnosis as the gold standard. Second, all ultrasound examiners in the study were experienced, and so our results may not be applicable with less experienced operators. However, published studies have shown that the Simple Rules retain their performance in the hands of less-experienced examiners. [10] [11] [12] [14] [15] [16] [17] This is likely to be also true of our Simple Rules risk calculation system, because the same ultrasound variables were used to calculate the risks.
Conclusions
We conclude that individual risk estimates can be derived from the 10 ultrasound features in the Simple Rules with performance similar to the best previously published algorithms. A simple classification based on these risk estimates may form the basis of a clinical management system. This will hopefully facilitate choosing optimal treatment for all patients presenting with adnexal masses. n
